Medscape: Skin adverse events rare after immunotherapy to treat skin cancers
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found certain skin adverse events were rare following immunotherapy treatments for certain skin cancers.
"Programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors are commonly used drugs for the treatment of various cancers," said Pushkar Aggarwal, MD, corresponding author and medical resident/fellow in UC's College of Medicine. "Having knowledge regarding possible associated skin reactions is vital for clinicians to guide management of the skin reaction and whether an adjustment is needed for the PD-1/PD-L1 inhibitors."
The researchers reviewed adverse event reports for patients treated with PD-1 and PD-L1 treatments between January 2004 and May 2023 to identify whether significant signals exist between PD-1/PD-L1 inhibitors and skin tumors keratoacanthoma and cutaneous squamous cell carcinoma (cSCC).
"For both keratoacanthoma and cSCC, significant signals were found with PD-1/PD-L1 inhibitors," Aggarwal said. But, out of 158,000 cases in the review, the data showed only 43 patients developing keratocanthoma and 83 developing cSCC, which highlights the conditions are "relatively rare adverse events."
Aggarwal said case reports, case-control trials and randomized clinical trials are needed to confirm the results of this study.
Featured photo at top of metastatic melanoma cells. Photo/National Cancer Institute.
Latest UC News
- Does CBD really work?The University of Cincinnati's LaTrice Montgomery and Michael Privitera joined WVXU's Cincinnati Edition to discuss how claims about CBD measure up to scientific research.
- Ex-smokers who vape at higher risk of lung cancerAshley Merianos, PhD, is cited as an expert in two recent Deutsche Welle articles on vaping research. Merianos, a prolific tobacco researcher, is an assistant professor of human services in UC's College of Education, Criminal Justice and Human Services (CECH).
- Engineering professor honored for distinguished scientific researchIn 2019, Munir Nazzal joined the University of Cincinnati College of Engineering and Applied Science as a professor in the Department of Civil and Architectural Engineering and Construction Management. Throughout his time at UC, he has received various accolades for his advancements in transportation research, including the UC George Rieveschl Jr. Award for Distinguished Scientific Research for 2024.
- UC study uses health factors to predict kidney function recoveryResearchers at the University of Cincinnati College of Medicine have created a scoring model that uses key health indicators to accurately predict recovery for patients who suffer kidney failure due to acute kidney injury (AKI).
- US Coast Guard Band's 'Heartland Harmonies' tour presents concert at CCMThe United States Coast Guard Band brings its "Heartland Harmonies" concert tour to UC's College-Conservatory of Music on Tuesday, June 25, 2024. The free concert is presented in Corbett Auditorium as part of the band's tour through the American South and Midwest regions for public performances and educational outreach.
- UC Clermont welcomes students from 50 states as programs, pathways increaseThe University of Cincinnati Clermont College now boasts students from all 50 states in the United States and overseas, thanks to a growing slate of online programs and innovative in-person and hybrid offerings.